Our group has previously shown that LPS treatment of newborn rodents recapitulates the alveolar simplification and impaired vascularization as observed in clinical BPD, by stimulating aberrant angiogenesis via TLR4-ERK-FOXC2-DLL4 signaling26,32. This evidence concerns the gene FOXC2 and bronchopulmonary dysplasia.